Page 924 - Small Animal Internal Medicine, 6th Edition
P. 924

896    PART VI   Endocrine Disorders




  VetBooks.ir  Drugs Used in Endocrine Disorders                            RECOMMENDED DOSAGE


             GENERIC NAME (TRADE
             NAME)                     PURPOSE                DOG                       CAT

             Calcium—injectable and oral   Treat hypocalcemia, Treat   See Box 53.7    See Box 53.7
               preps                    hypoparathyroidism
             Carbimazole               Treat feline           NA                       2.5-5 mg PO q12h initially;
               (Neo-Mercazole)          hyperthyroidism                                  increase q2wk to effect
             Chlorpropamide (Diabinase)  Treat partial central   5-20 mg/kg PO q12h    Unknown
                                        diabetes insipidus
             Chlorothiazide (Diuril)   Treat central/renal    20-40 mg/kg PO q12h      20-40 mg/kg PO q12h
                                        diabetes insipidus
             Desmopressin (DDAVP)      Treat central diabetes   1-4 drops of nasal spray in   1-4 drops of nasal spray in
                                        insipidus               conjunctival sac q12-24h;   conjunctival sac q12-24h;
                                                                tablets: 0.05-0.2 mg/dog   tablets: 0.05 mg/cat PO
                                                                PO q8-12h                q8-12h
             Desoxycorticosterone pivalate   Treat hypoadrenocorticism  2.2 mg/kg, IM or SC, q25d   2.2 mg/kg, IM or SC, q25d
               (DOCP)                                           initially                initially
             Dexamethasone sodium      Treat acute addisonian   0.5-1 mg/kg IV, repeat   0.5-1 mg/kg IV, repeat q12h
               phosphate                crisis                  q12h at 0.05-0.1 mg/kg   at 0.05-0.1 mg/kg in IV
                                                                in IV fluids             fluids
             Diazoxide (Proglycem)     Treat hypoglycemia     5 mg/kg PO q12h initially  Unknown
                                        caused by β-cell
                                        neoplasia
             Fludrocortisone acetate   Treat hypoadrenocorticism  0.01 mg/kg PO q12h   0.05-0.1 mg/cat PO
               (Florinef)                                       initially
             Glucagon USP              Treat hypoglycemia     5-10 ng/kg/min as         Unknown
                                        caused by a β-cell      continuous IV infusion;
                                        neoplasia               adjust dose to effect
             Growth hormone—porcine    Treat pituitary dwarfism  0.1 IU/kg SC 3 times/wk   Unknown
               origin                                           for 4-6 weeks
             Insulin                   Treat diabetic ketoacidosis  See Box 49.11       See Box 49.11
                                       Treat diabetes mellitus  See Table 49.3          See Table 49.3
                                       Provide supportive     See Table 53.3            See Table 53.3
                                        treatment for
                                        hyperkalemia
             Ketoconazole (Nizoral     Treat                  5 mg/kg PO q12h initially,   Not recommended
                                        hyperadrenocorticism    increase to effect q2wk
             Melatonin                 Treat alopecia X       3 mg (dogs ≤ 15 kg) or    NA
                                        syndrome                6 mg (dogs >15 kg) PO
                                                                q12h for 6-8 weeks
                                                                initially
             Methimazole (Felimazole)  Treat hyperthyroidism  2.5 mg/dog PO q12h       2.5 mg/cat PO q12h initially;
                                                                initially; increase q2wk to   increase q2wk to effect
                                                                effect
             o,p′DDD (Mitotane, Lysodren)  Treat canine       Induction: 25 mg/kg PO    Not recommended
                                        hyperadrenocorticism    q12h until controlled
                                       Long-term treatment of   Maintenance: 25-50 mg/kg
                                        hypoadrenocorticism     PO per week initially
                                                                divided into 2 or 3 doses
             Phenoxybenzamine          Supportive treatment   0.5 mg/kg PO q12h         Unknown
               (Dibenzyline)            forpheochromocytoma     initially, gradually increase
                                                                to effect
   919   920   921   922   923   924   925   926   927   928   929